Home LiteratureArticle Details
PMID: 7588857 Published · ppublish English Journal Article Review

Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA.

Craig WA

Abstract

A variety of pharmacodynamic, pharmacokinetic and drug stability factors can influence the choice of drug, the dosing regimen and the method of drug administration for out-patient parenteral antibiotic therapy (OPAT). Beta-lactam antibiotics exhibit little if any concentration-dependent killing and produce short-term or no persistent effects with most bacterial pathogens. Optimal dosing regimens for these agents should provide serum levels that continually exceed the minimal inhibitory concentration (MIC) of the pathogen. Beta-lactam agents with long half-lives (greater than 2 hours) can provide these levels with intermittent dosing once or twice daily. Beta-lactam agents with shorter half-lives can be administered by programmable pumps or by continuous infusion providing the drug is sufficiently stable to degradation in solution. Imipenem and ampicillin are examples of drugs with short half-lives that are unstable in solution and must be dosed intermittently. Intramuscular administration slows absorption and can also prolong the length of time during which serum levels exceed the MIC of infecting bacteria. Aminoglycosides and fluoroquinolones, on the other hand, exhibit concentration-dependent killing and produce prolonged persistent effects. Optimal dosage regimens of these drugs should maximize serum levels. Once-daily dosing regimens for the aminoglycosides meet this goal and also appear to reduce drug-induced nephrotoxicity. Application of these principles to drug selection and administration in a hospital-based OPAT program has provided efficacious therapy and a low incidence of adverse reactions in an elderly population distributed over a wide geographic area.

MeSH Terms
Anti-Bacterial Agents/pharmacokinetics,pharmacology,therapeutic use Drug Stability Humans Outpatient Clinics, Hospital
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Craig W A
Department of Medicine, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin 53705, USA.
References (26)
26 references, click to expand
  1. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.
    Antimicrob Agents Chemother. 1987 Jul;31(7):1054-60 PMID: 3116917
  2. Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man.
    J Antimicrob Chemother. 1991 May;27 Suppl C:41-7 PMID: 1856145
  3. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.
    Antimicrob Agents Chemother. 1993 May;37(5):1073-81 PMID: 8517694
  4. Intramuscular ceftriaxone in home parenteral therapy.
    Antimicrob Agents Chemother. 1988 Sep;32(9):1439-40 PMID: 3196006
  5. Role for dual individualization with cefmenoxime.
    Am J Med. 1984 Dec 21;77(6A):43-50 PMID: 6097124
  6. Once-daily dosing decreases renal accumulation of gentamicin and netilmicin.
    Clin Pharmacol Ther. 1989 Jan;45(1):22-7 PMID: 2910634
  7. Killing and regrowth of bacteria in vitro: a review.
    Scand J Infect Dis Suppl. 1990;74:63-70 PMID: 2097720
  8. Clinical pharmacokinetics of continuous intravenous administration of penicillins.
    Clin Infect Dis. 1993 Sep;17(3):491-5 PMID: 8218695
  9. Effect of storage of penicillin-G solutions on sensitisation to penicillin-G after intravenous administration.
    Lancet. 1982 May 1;1(8279):986-8 PMID: 6122846
  10. Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.
    J Antimicrob Chemother. 1993 May;31 Suppl D:149-58 PMID: 8335516
  11. Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections.
    J Antimicrob Chemother. 1991 May;27 Suppl C:29-40 PMID: 1830302
  12. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model.
    J Infect Dis. 1988 Oct;158(4):831-47 PMID: 3139779
  13. Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes.
    Rev Infect Dis. 1981 Jan-Feb;3(1):38-44 PMID: 7012999
  14. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.
    J Infect Dis. 1987 Jan;155(1):93-9 PMID: 3540140
  15. Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis.
    Am J Med. 1987 Aug;83(2):218-22 PMID: 3303925
  16. Postantibiotic effects.
    J Antimicrob Chemother. 1985 Jan;15 Suppl A:37-46 PMID: 3980335
  17. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
    J Infect Dis. 1989 Feb;159(2):281-92 PMID: 2644371
  18. Adverse reactions following intravenous penicillin-G relate to degradation of the drug in vitro.
    Klin Wochenschr. 1984 Jan 2;62(1):25-9 PMID: 6230485
  19. Home intravenous antibiotic therapy using a programmable infusion pump.
    Arch Intern Med. 1989 May;149(5):1157-60 PMID: 2719507
  20. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis.
    Antimicrob Agents Chemother. 1992 Mar;36(3):540-4 PMID: 1622162
  21. Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic.
    Hosp Pract (Off Ed). 1993 Jun;28 Suppl 1:16-20 PMID: 8505393
  22. Pharmacodynamic effects of subinhibitory antibiotic concentrations.
    Scand J Infect Dis Suppl. 1990;74:94-101 PMID: 2097721
  23. Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment.
    J Infect Dis. 1988 Jun;157(6):1150-7 PMID: 2897398
  24. Continuous infusion of beta-lactam antibiotics.
    Antimicrob Agents Chemother. 1992 Dec;36(12):2577-83 PMID: 1482127
  25. Determinants of efficacy and toxicity of aminoglycosides.
    J Antimicrob Chemother. 1989 Sep;24(3):281-93 PMID: 2681115
  26. Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens.
    Antimicrob Agents Chemother. 1992 Jan;36(1):121-5 PMID: 1590676
Article Info
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Abbr.
Eur J Clin Microbiol Infect Dis
ISSN
0934-9723
Published
1995-07-00
Pages
636-42
Language
English
Region
Germany
NLM ID
8804297
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com